What's Happening?
The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for Ivomec (ivermectin) 1% Injection, a preventive measure against New World Screwworm (NWS) in cattle. This authorization, secured by Boehringer Ingelheim, allows
the use of the product in specific situations such as within 24 hours of birth, during castration, or when a wound appears. The EUA is a response to the lack of adequate, approved alternatives for preventing NWS infestations, which pose a significant threat to cattle health. The USDA is also actively monitoring the northward spread of NWS, which has been reported close to the U.S.-Mexico border.
Why It's Important?
The EUA for Ivomec (ivermectin) 1% Injection is crucial for cattle producers and veterinarians as it provides a necessary tool to prevent NWS infestations, which can severely impact cattle health and the livestock industry. The proactive measures by the FDA and USDA highlight the importance of safeguarding the U.S. cattle industry from emerging threats. This authorization not only helps protect animal health but also supports the livelihoods of cattle producers by ensuring the stability of the food supply chain.
What's Next?
The EUA remains in effect as long as the circumstances justifying its issuance persist. The USDA's comprehensive prevention plan will continue to address the threat of NWS, especially as it approaches the U.S. border. Ongoing monitoring and potential adjustments to the authorization may occur based on the evolving situation and the effectiveness of the preventive measures.
